<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Studies on the Effectiveness of Nonsurgical Treatments in Cirrhosis — dat.pagliaro1992 • metafor</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cosmo/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Studies on the Effectiveness of Nonsurgical Treatments in Cirrhosis — dat.pagliaro1992" />
<meta property="og:description" content="Results from 26 trials examining the effectiveness of beta-blockers and sclerotherapy for the prevention of first bleeding in patients with cirrhosis" />




<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">metafor</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">2.5-36</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/metafor-package.html">Intro</a>
</li>
<li>
  <a href="../reference/index.html">Functions</a>
</li>
<li>
  <a href="../articles/pkgdown/diagram.html">Diagram</a>
</li>
<li>
  <a href="https://www.jstatsoft.org/index.php/jss/article/view/v036i03/v36i03.pdf">JSS Article (pdf)</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://twitter.com/wviechtb">
    <span class="fa fa-twitter"></span>
     
  </a>
</li>
<li>
  <a href="https://github.com/wviechtb/metafor">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Studies on the Effectiveness of Nonsurgical Treatments in Cirrhosis</h1>
    
    <div class="hidden name"><code>dat.pagliaro1992.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Results from 26 trials examining the effectiveness of beta-blockers and sclerotherapy for the prevention of first bleeding in patients with cirrhosis</p>
    </div>

    <pre class="usage"><span class='no'>dat.pagliaro1992</span></pre>


    <h2 class="hasAnchor" id="format"><a class="anchor" href="#format"></a>Format</h2>

    <p>The data frame contains the following columns:</p><table class='table'>
<tr><td><b>study</b></td><td><code>numeric</code></td><td>study id</td></tr>
<tr><td><b>trt</b></td><td><code>character</code></td><td>either beta-blockers, sclerotherapy, or control</td></tr>
<tr><td><b>xi</b></td><td><code>numeric</code></td><td>number of patients with first bleeding</td></tr>
<tr><td><b>ni</b></td><td><code>numeric</code></td><td>number of patients treated</td></tr>
</table>


    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    <p>The dataset includes the results from 26 randomized controlled trials examining the effectiveness of nonsurgical treatments for the prevention of first bleeding in patients with cirrhosis. Patients were either treated with beta-blockers, endoscopic sclerotherapy, or with a nonactive treatment (control). Two trials included all three treatment conditions, 7 trials compared beta-blockers against control, and 17 trials compared sclerotherapy against control. The dataset has been used in various papers to illustrate methods for conducting a network meta-analysis / mixed treatment comparison.</p>
    <h2 class="hasAnchor" id="source"><a class="anchor" href="#source"></a>Source</h2>

    <p>Pagliaro, L., D'Amico, G., Sörensen, T. I. A., Lebrec, D., Burroughs, A. K., Morabito, A., Tiné, F., Politi, F., &amp; Traina, M. (1992). Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of nonsurgical treatment. <em>Annals of Internal Medicine</em>, <b>117</b>(1), 59--70. <a href='https://doi.org/10.7326/0003-4819-117-1-59'>https://doi.org/10.7326/0003-4819-117-1-59</a></p>

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><div class='input'><span class='co'>### copy data into 'dat' and examine data</span>
<span class='no'>dat</span> <span class='kw'>&lt;-</span> <span class='no'>dat.pagliaro1992</span>
<span class='no'>dat</span></div><div class='output co'>#&gt;    study           trt xi  ni
#&gt; 1      1 beta-blockers  2  43
#&gt; 2      1 sclerotherapy  9  42
#&gt; 3      1       control 13  41
#&gt; 4      2 beta-blockers 12  68
#&gt; 5      2 sclerotherapy 13  73
#&gt; 6      2       control 13  72
#&gt; 7      3 beta-blockers  4  20
#&gt; 8      3       control  4  16
#&gt; 9      4 beta-blockers 20 116
#&gt; 10     4       control 30 111
#&gt; 11     5 beta-blockers  1  30
#&gt; 12     5       control 11  49
#&gt; 13     6 beta-blockers  7  53
#&gt; 14     6       control 10  53
#&gt; 15     7 beta-blockers 18  85
#&gt; 16     7       control 31  89
#&gt; 17     8 beta-blockers  2  51
#&gt; 18     8       control 11  51
#&gt; 19     9 beta-blockers  8  23
#&gt; 20     9       control  2  25
#&gt; 21    10 sclerotherapy  4  18
#&gt; 22    10       control  0  19
#&gt; 23    11 sclerotherapy  3  35
#&gt; 24    11       control 22  36
#&gt; 25    12 sclerotherapy  5  56
#&gt; 26    12       control 30  53
#&gt; 27    13 sclerotherapy  5  16
#&gt; 28    13       control  6  18
#&gt; 29    14 sclerotherapy  3  23
#&gt; 30    14       control  9  22
#&gt; 31    15 sclerotherapy 11  49
#&gt; 32    15       control 31  46
#&gt; 33    16 sclerotherapy 19  53
#&gt; 34    16       control  9  60
#&gt; 35    17 sclerotherapy 17  53
#&gt; 36    17       control 26  60
#&gt; 37    18 sclerotherapy 10  71
#&gt; 38    18       control 29  69
#&gt; 39    19 sclerotherapy 12  41
#&gt; 40    19       control 14  41
#&gt; 41    20 sclerotherapy  0  21
#&gt; 42    20       control  3  20
#&gt; 43    21 sclerotherapy 13  33
#&gt; 44    21       control 14  35
#&gt; 45    22 sclerotherapy 31 143
#&gt; 46    22       control 23 138
#&gt; 47    23 sclerotherapy 20  55
#&gt; 48    23       control 19  51
#&gt; 49    24 sclerotherapy  3  13
#&gt; 50    24       control 12  16
#&gt; 51    25 sclerotherapy  3  21
#&gt; 52    25       control  5  28
#&gt; 53    26 sclerotherapy  6  22
#&gt; 54    26       control  2  24</div><div class='input'>
<span class='co'>### restructure dataset to a contrast-based format</span>
<span class='no'>dat.c</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='to.wide.html'>to.wide</a></span>(<span class='no'>dat</span>, <span class='kw'>study</span><span class='kw'>=</span><span class='st'>"study"</span>, <span class='kw'>grp</span><span class='kw'>=</span><span class='st'>"trt"</span>, <span class='kw'>grpvars</span><span class='kw'>=</span><span class='fl'>3</span>:<span class='fl'>4</span>)
<span class='no'>dat.c</span></div><div class='output co'>#&gt;    study         trt.1 xi.1 ni.1   trt.2 xi.2 ni.2 id  comp   design
#&gt; 1      1 beta-blockers    2   43 control   13   41  1 be-co be-sc-co
#&gt; 2      1 sclerotherapy    9   42 control   13   41  2 sc-co be-sc-co
#&gt; 3      2 beta-blockers   12   68 control   13   72  3 be-co be-sc-co
#&gt; 4      2 sclerotherapy   13   73 control   13   72  4 sc-co be-sc-co
#&gt; 5      3 beta-blockers    4   20 control    4   16  5 be-co    be-co
#&gt; 6      4 beta-blockers   20  116 control   30  111  6 be-co    be-co
#&gt; 7      5 beta-blockers    1   30 control   11   49  7 be-co    be-co
#&gt; 8      6 beta-blockers    7   53 control   10   53  8 be-co    be-co
#&gt; 9      7 beta-blockers   18   85 control   31   89  9 be-co    be-co
#&gt; 10     8 beta-blockers    2   51 control   11   51 10 be-co    be-co
#&gt; 11     9 beta-blockers    8   23 control    2   25 11 be-co    be-co
#&gt; 12    10 sclerotherapy    4   18 control    0   19 12 sc-co    sc-co
#&gt; 13    11 sclerotherapy    3   35 control   22   36 13 sc-co    sc-co
#&gt; 14    12 sclerotherapy    5   56 control   30   53 14 sc-co    sc-co
#&gt; 15    13 sclerotherapy    5   16 control    6   18 15 sc-co    sc-co
#&gt; 16    14 sclerotherapy    3   23 control    9   22 16 sc-co    sc-co
#&gt; 17    15 sclerotherapy   11   49 control   31   46 17 sc-co    sc-co
#&gt; 18    16 sclerotherapy   19   53 control    9   60 18 sc-co    sc-co
#&gt; 19    17 sclerotherapy   17   53 control   26   60 19 sc-co    sc-co
#&gt; 20    18 sclerotherapy   10   71 control   29   69 20 sc-co    sc-co
#&gt; 21    19 sclerotherapy   12   41 control   14   41 21 sc-co    sc-co
#&gt; 22    20 sclerotherapy    0   21 control    3   20 22 sc-co    sc-co
#&gt; 23    21 sclerotherapy   13   33 control   14   35 23 sc-co    sc-co
#&gt; 24    22 sclerotherapy   31  143 control   23  138 24 sc-co    sc-co
#&gt; 25    23 sclerotherapy   20   55 control   19   51 25 sc-co    sc-co
#&gt; 26    24 sclerotherapy    3   13 control   12   16 26 sc-co    sc-co
#&gt; 27    25 sclerotherapy    3   21 control    5   28 27 sc-co    sc-co
#&gt; 28    26 sclerotherapy    6   22 control    2   24 28 sc-co    sc-co</div><div class='input'>
<span class='co'>### Mantel-Haenszel results for beta-blockers and sclerotherapy versus control, respectively</span>
<span class='fu'><a href='rma.mh.html'>rma.mh</a></span>(<span class='kw'>measure</span><span class='kw'>=</span><span class='st'>"OR"</span>, <span class='kw'>ai</span><span class='kw'>=</span><span class='no'>xi.1</span>, <span class='kw'>n1i</span><span class='kw'>=</span><span class='no'>ni.1</span>, <span class='kw'>ci</span><span class='kw'>=</span><span class='no'>xi.2</span>, <span class='kw'>n2i</span><span class='kw'>=</span><span class='no'>ni.2</span>,
       <span class='kw'>data</span><span class='kw'>=</span><span class='no'>dat.c</span>, <span class='kw'>subset</span><span class='kw'>=</span>(<span class='no'>trt.1</span><span class='kw'>==</span><span class='st'>"beta-blockers"</span>), <span class='kw'>digits</span><span class='kw'>=</span><span class='fl'>2</span>)</div><div class='output co'>#&gt; 
#&gt; Fixed-Effects Model (k = 9)
#&gt; 
#&gt; I^2 (total heterogeneity / total variability):  57.85%
#&gt; H^2 (total variability / sampling variability): 2.37
#&gt; 
#&gt; Test for Heterogeneity: 
#&gt; Q(df = 8) = 18.98, p-val = 0.01
#&gt; 
#&gt; Model Results (log scale):
#&gt; 
#&gt; estimate    se   zval  pval  ci.lb  ci.ub 
#&gt;    -0.62  0.16  -3.78  &lt;.01  -0.94  -0.30 
#&gt; 
#&gt; Model Results (OR scale):
#&gt; 
#&gt; estimate  ci.lb  ci.ub 
#&gt;     0.54   0.39   0.74 
#&gt; 
#&gt; Cochran-Mantel-Haenszel Test:    CMH = 14.14, df = 1, p-val &lt; 0.01
#&gt; Tarone's Test for Heterogeneity: X^2 = 22.76, df = 8, p-val &lt; 0.01
#&gt; </div><div class='input'><span class='fu'><a href='rma.mh.html'>rma.mh</a></span>(<span class='kw'>measure</span><span class='kw'>=</span><span class='st'>"OR"</span>, <span class='kw'>ai</span><span class='kw'>=</span><span class='no'>xi.1</span>, <span class='kw'>n1i</span><span class='kw'>=</span><span class='no'>ni.1</span>, <span class='kw'>ci</span><span class='kw'>=</span><span class='no'>xi.2</span>, <span class='kw'>n2i</span><span class='kw'>=</span><span class='no'>ni.2</span>,
       <span class='kw'>data</span><span class='kw'>=</span><span class='no'>dat.c</span>, <span class='kw'>subset</span><span class='kw'>=</span>(<span class='no'>trt.1</span><span class='kw'>==</span><span class='st'>"sclerotherapy"</span>), <span class='kw'>digits</span><span class='kw'>=</span><span class='fl'>2</span>)</div><div class='output co'>#&gt; 
#&gt; Fixed-Effects Model (k = 19)
#&gt; 
#&gt; I^2 (total heterogeneity / total variability):  77.94%
#&gt; H^2 (total variability / sampling variability): 4.53
#&gt; 
#&gt; Test for Heterogeneity: 
#&gt; Q(df = 18) = 81.60, p-val &lt; .01
#&gt; 
#&gt; Model Results (log scale):
#&gt; 
#&gt; estimate    se   zval  pval  ci.lb  ci.ub 
#&gt;    -0.53  0.11  -4.84  &lt;.01  -0.74  -0.31 
#&gt; 
#&gt; Model Results (OR scale):
#&gt; 
#&gt; estimate  ci.lb  ci.ub 
#&gt;     0.59   0.48   0.73 
#&gt; 
#&gt; Cochran-Mantel-Haenszel Test:    CMH = 24.20, df = 1,  p-val &lt; 0.01
#&gt; Tarone's Test for Heterogeneity: X^2 = 94.46, df = 18, p-val &lt; 0.01
#&gt; </div><div class='input'>
<span class='co'>### calculate log odds for each study arm</span>
<span class='no'>dat</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='escalc.html'>escalc</a></span>(<span class='kw'>measure</span><span class='kw'>=</span><span class='st'>"PLO"</span>, <span class='kw'>xi</span><span class='kw'>=</span><span class='no'>xi</span>, <span class='kw'>ni</span><span class='kw'>=</span><span class='no'>ni</span>, <span class='kw'>data</span><span class='kw'>=</span><span class='no'>dat</span>)
<span class='no'>dat</span></div><div class='output co'>#&gt;    study           trt xi  ni      yi     vi 
#&gt; 1      1 beta-blockers  2  43 -3.0204 0.5244 
#&gt; 2      1 sclerotherapy  9  42 -1.2993 0.1414 
#&gt; 3      1       control 13  41 -0.7673 0.1126 
#&gt; 4      2 beta-blockers 12  68 -1.5404 0.1012 
#&gt; 5      2 sclerotherapy 13  73 -1.5294 0.0936 
#&gt; 6      2       control 13  72 -1.5126 0.0939 
#&gt; 7      3 beta-blockers  4  20 -1.3863 0.3125 
#&gt; 8      3       control  4  16 -1.0986 0.3333 
#&gt; 9      4 beta-blockers 20 116 -1.5686 0.0604 
#&gt; 10     4       control 30 111 -0.9933 0.0457 
#&gt; 11     5 beta-blockers  1  30 -3.3673 1.0345 
#&gt; 12     5       control 11  49 -1.2397 0.1172 
#&gt; 13     6 beta-blockers  7  53 -1.8827 0.1646 
#&gt; 14     6       control 10  53 -1.4586 0.1233 
#&gt; 15     7 beta-blockers 18  85 -1.3143 0.0705 
#&gt; 16     7       control 31  89 -0.6265 0.0495 
#&gt; 17     8 beta-blockers  2  51 -3.1987 0.5204 
#&gt; 18     8       control 11  51 -1.2910 0.1159 
#&gt; 19     9 beta-blockers  8  23 -0.6286 0.1917 
#&gt; 20     9       control  2  25 -2.4423 0.5435 
#&gt; 21    10 sclerotherapy  4  18 -1.2528 0.3214 
#&gt; 22    10       control  0  19 -3.6636 2.0513 
#&gt; 23    11 sclerotherapy  3  35 -2.3671 0.3646 
#&gt; 24    11       control 22  36  0.4520 0.1169 
#&gt; 25    12 sclerotherapy  5  56 -2.3224 0.2196 
#&gt; 26    12       control 30  53  0.2657 0.0768 
#&gt; 27    13 sclerotherapy  5  16 -0.7885 0.2909 
#&gt; 28    13       control  6  18 -0.6931 0.2500 
#&gt; 29    14 sclerotherapy  3  23 -1.8971 0.3833 
#&gt; 30    14       control  9  22 -0.3677 0.1880 
#&gt; 31    15 sclerotherapy 11  49 -1.2397 0.1172 
#&gt; 32    15       control 31  46  0.7259 0.0989 
#&gt; 33    16 sclerotherapy 19  53 -0.5819 0.0820 
#&gt; 34    16       control  9  60 -1.7346 0.1307 
#&gt; 35    17 sclerotherapy 17  53 -0.7503 0.0866 
#&gt; 36    17       control 26  60 -0.2683 0.0679 
#&gt; 37    18 sclerotherapy 10  71 -1.8083 0.1164 
#&gt; 38    18       control 29  69 -0.3216 0.0595 
#&gt; 39    19 sclerotherapy 12  41 -0.8824 0.1178 
#&gt; 40    19       control 14  41 -0.6568 0.1085 
#&gt; 41    20 sclerotherapy  0  21 -3.7612 2.0465 
#&gt; 42    20       control  3  20 -1.7346 0.3922 
#&gt; 43    21 sclerotherapy 13  33 -0.4308 0.1269 
#&gt; 44    21       control 14  35 -0.4055 0.1190 
#&gt; 45    22 sclerotherapy 31 143 -1.2845 0.0412 
#&gt; 46    22       control 23 138 -1.6094 0.0522 
#&gt; 47    23 sclerotherapy 20  55 -0.5596 0.0786 
#&gt; 48    23       control 19  51 -0.5213 0.0839 
#&gt; 49    24 sclerotherapy  3  13 -1.2040 0.4333 
#&gt; 50    24       control 12  16  1.0986 0.3333 
#&gt; 51    25 sclerotherapy  3  21 -1.7918 0.3889 
#&gt; 52    25       control  5  28 -1.5261 0.2435 
#&gt; 53    26 sclerotherapy  6  22 -0.9808 0.2292 
#&gt; 54    26       control  2  24 -2.3979 0.5455 </div><div class='input'>
<span class='co'>### turn treatment variable into factor and set reference level</span>
<span class='no'>dat</span>$<span class='no'>trt</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/stats/relevel.html'>relevel</a></span>(<span class='fu'><a href='https://rdrr.io/r/base/factor.html'>factor</a></span>(<span class='no'>dat</span>$<span class='no'>trt</span>), <span class='kw'>ref</span><span class='kw'>=</span><span class='st'>"control"</span>)

<span class='co'>### add a space before each level (this makes the output a bit more legible)</span>
<span class='fu'><a href='https://rdrr.io/r/base/levels.html'>levels</a></span>(<span class='no'>dat</span>$<span class='no'>trt</span>) <span class='kw'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/paste.html'>paste0</a></span>(<span class='st'>" "</span>, <span class='fu'><a href='https://rdrr.io/r/base/levels.html'>levels</a></span>(<span class='no'>dat</span>$<span class='no'>trt</span>))

<span class='co'>### network meta-analysis using an arm-based random-effects model with fixed study effects</span>
<span class='co'>### (by setting rho=1/2, tau^2 reflects the amount of heterogeneity for all treatment comparisons)</span>
<span class='no'>res</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='rma.mv.html'>rma.mv</a></span>(<span class='no'>yi</span>, <span class='no'>vi</span>, <span class='kw'>mods</span> <span class='kw'>=</span> ~ <span class='fu'><a href='https://rdrr.io/r/base/factor.html'>factor</a></span>(<span class='no'>study</span>) + <span class='no'>trt</span> - <span class='fl'>1</span>, <span class='kw'>random</span> <span class='kw'>=</span> ~ <span class='no'>trt</span> <span class='kw'>|</span> <span class='no'>study</span>, <span class='kw'>rho</span><span class='kw'>=</span><span class='fl'>1</span>/<span class='fl'>2</span>, <span class='kw'>data</span><span class='kw'>=</span><span class='no'>dat</span>)
<span class='no'>res</span></div><div class='output co'>#&gt; 
#&gt; Multivariate Meta-Analysis Model (k = 54; method: REML)
#&gt; 
#&gt; Variance Components:
#&gt; 
#&gt; outer factor: study (nlvls = 26)
#&gt; inner factor: trt   (nlvls = 3)
#&gt; 
#&gt;             estim    sqrt  fixed 
#&gt; tau^2      0.9913  0.9957     no 
#&gt; rho        0.5000            yes 
#&gt; 
#&gt; Test for Residual Heterogeneity:
#&gt; QE(df = 26) = 99.3092, p-val &lt; .0001
#&gt; 
#&gt; Test of Moderators (coefficients 1:28):
#&gt; QM(df = 28) = 56.4980, p-val = 0.0011
#&gt; 
#&gt; Model Results:
#&gt; 
#&gt;                    estimate      se     zval    pval    ci.lb    ci.ub 
#&gt; factor(study)1      -1.1071  0.8684  -1.2748  0.2024  -2.8091   0.5950    
#&gt; factor(study)2      -1.0951  0.8483  -1.2910  0.1967  -2.7577   0.5675    
#&gt; factor(study)3      -0.8816  0.9712  -0.9077  0.3641  -2.7851   1.0220    
#&gt; factor(study)4      -0.9237  0.8980  -1.0286  0.3037  -2.6838   0.8364    
#&gt; factor(study)5      -1.6433  0.9724  -1.6900  0.0910  -3.5491   0.2625  . 
#&gt; factor(study)6      -1.3172  0.9221  -1.4286  0.1531  -3.1244   0.4900    
#&gt; factor(study)7      -0.6125  0.8997  -0.6808  0.4960  -2.3758   1.1509    
#&gt; factor(study)8      -1.7386  0.9479  -1.8341  0.0666  -3.5966   0.1193  . 
#&gt; factor(study)9      -0.9195  0.9816  -0.9367  0.3489  -2.8435   1.0045    
#&gt; factor(study)10     -1.3962  1.0750  -1.2988  0.1940  -3.5032   0.7107    
#&gt; factor(study)11     -0.4776  0.9305  -0.5133  0.6077  -2.3015   1.3462    
#&gt; factor(study)12     -0.6253  0.9099  -0.6872  0.4920  -2.4086   1.1581    
#&gt; factor(study)13     -0.4554  0.9463  -0.4812  0.6304  -2.3101   1.3994    
#&gt; factor(study)14     -0.7814  0.9455  -0.8264  0.4086  -2.6346   1.0718    
#&gt; factor(study)15      0.0456  0.9027   0.0505  0.9597  -1.7238   1.8149    
#&gt; factor(study)16     -0.8312  0.9032  -0.9203  0.3574  -2.6014   0.9390    
#&gt; factor(study)17     -0.2181  0.8941  -0.2440  0.8072  -1.9706   1.5343    
#&gt; factor(study)18     -0.7510  0.8961  -0.8380  0.4020  -2.5074   1.0055    
#&gt; factor(study)19     -0.4790  0.9043  -0.5297  0.5963  -2.2514   1.2934    
#&gt; factor(study)20     -2.1080  1.0763  -1.9585  0.0502  -4.2176   0.0016  . 
#&gt; factor(study)21     -0.1279  0.9071  -0.1410  0.8878  -1.9057   1.6499    
#&gt; factor(study)22     -1.1504  0.8861  -1.2983  0.1942  -2.8871   0.5863    
#&gt; factor(study)23     -0.2472  0.8957  -0.2760  0.7825  -2.0028   1.5083    
#&gt; factor(study)24      0.2882  0.9746   0.2957  0.7675  -1.6219   2.1983    
#&gt; factor(study)25     -1.3812  0.9557  -1.4453  0.1484  -3.2542   0.4919    
#&gt; factor(study)26     -1.2182  0.9737  -1.2511  0.2109  -3.1266   0.6902    
#&gt; trt beta-blockers   -0.7163  0.3871  -1.8508  0.0642  -1.4750   0.0423  . 
#&gt; trt sclerotherapy   -0.5839  0.2684  -2.1753  0.0296  -1.1101  -0.0578  * 
#&gt; 
#&gt; ---
#&gt; Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
#&gt; </div><div class='input'>
<span class='co'>### average odds ratio comparing beta-blockers and sclerotherapy versus control, respectively</span>
<span class='fu'><a href='predict.rma.html'>predict</a></span>(<span class='no'>res</span>, <span class='kw'>newmods</span><span class='kw'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fu'><a href='https://rdrr.io/r/base/rep.html'>rep</a></span>(<span class='fl'>0</span>,<span class='fl'>26</span>), <span class='fl'>1</span>, <span class='fl'>0</span>), <span class='kw'>transf</span><span class='kw'>=</span><span class='no'>exp</span>, <span class='kw'>digits</span><span class='kw'>=</span><span class='fl'>2</span>)</div><div class='output co'>#&gt; 
#&gt;  pred ci.lb ci.ub pi.lb pi.ub 
#&gt;  0.49  0.23  1.04  0.06  3.96 
#&gt; </div><div class='input'><span class='fu'><a href='predict.rma.html'>predict</a></span>(<span class='no'>res</span>, <span class='kw'>newmods</span><span class='kw'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fu'><a href='https://rdrr.io/r/base/rep.html'>rep</a></span>(<span class='fl'>0</span>,<span class='fl'>26</span>), <span class='fl'>0</span>, <span class='fl'>1</span>), <span class='kw'>transf</span><span class='kw'>=</span><span class='no'>exp</span>, <span class='kw'>digits</span><span class='kw'>=</span><span class='fl'>2</span>)</div><div class='output co'>#&gt; 
#&gt;  pred ci.lb ci.ub pi.lb pi.ub 
#&gt;  0.56  0.33  0.94  0.07  4.21 
#&gt; </div><div class='input'>
<span class='co'>### average odds ratio comparing beta-blockers versus sclerotherapy</span>
<span class='fu'><a href='predict.rma.html'>predict</a></span>(<span class='no'>res</span>, <span class='kw'>newmods</span><span class='kw'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fu'><a href='https://rdrr.io/r/base/rep.html'>rep</a></span>(<span class='fl'>0</span>,<span class='fl'>26</span>), <span class='fl'>1</span>, -<span class='fl'>1</span>), <span class='kw'>transf</span><span class='kw'>=</span><span class='no'>exp</span>, <span class='kw'>digits</span><span class='kw'>=</span><span class='fl'>2</span>)</div><div class='output co'>#&gt; 
#&gt;  pred ci.lb ci.ub pi.lb pi.ub 
#&gt;  0.88  0.36  2.11  0.10  7.45 
#&gt; </div></pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by Wolfgang Viechtbauer.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.5.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


